Reporting of activated partial thromboplastin time (aPTT): Could we achieve better comparability of the results?

activated partial thromboplastin time external quality assessment harmonization

Journal

Biochemia medica
ISSN: 1846-7482
Titre abrégé: Biochem Med (Zagreb)
Pays: Croatia
ID NLM: 9610305

Informations de publication

Date de publication:
15 Jun 2021
Historique:
received: 09 09 2020
accepted: 09 03 2021
entrez: 18 6 2021
pubmed: 19 6 2021
medline: 20 8 2021
Statut: ppublish

Résumé

Activated partial thromboplastin time (aPTT) is determined and reported as clotting time in seconds aPTT(s), but it is presumed that reporting results as patient-to-normal clotting time ratio, aPTT(r), could minimize within-laboratory variability. The aim of study was to investigate differences in reporting aPTT results that can affect comparability of the results among Croatian laboratories and suggest further steps for its harmonization. The questionnaire on aPTT reporting practice was distributed to 83 laboratories through Survey Monkey application in March 2019 as the part of the first regular round of Croatian Centre for Quality Assessment in Laboratory Medicine proficiency testing. The survey response rate was 0.49. Majority of laboratories report aPTT results as both, seconds and ratio. Participants reported use of 23 different aPTT(s) reference intervals along with 17 different combinations of reagent/coagulometer and 25 aPTT(s) denominators of different origin for aPTT(r) calculation. Despite the same aPTT(s) results, the use of different denominators caused a dispersion of aPTT(r) results that can lead to exceeding external quality assessment performance criteria of 7%, particularly when results were compared for the same reagent group only. By applying aPTT(s) reference interval mean as denominator for calculation of aPTT(r) reference interval better concordance to harmonized one was obtained (17 In order to improve comparability of the results, laboratories are advised to use mean of aPTT(s) reference interval as denominator for aPTT(r) calculation. Type of coagulometer need to be considered when evaluating aPTT proficiency test results and its currently acceptable limit of performance evaluated accordingly.

Identifiants

pubmed: 34140831
doi: 10.11613/BM.2021.020708
pii: bm-31-2-020708
pmc: PMC8183120
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

020708

Informations de copyright

Croatian Society of Medical Biochemistry and Laboratory Medicine.

Déclaration de conflit d'intérêts

Potential conflict of interest None declared.

Références

Blood Coagul Fibrinolysis. 2018 Jan;29(1):111-119
pubmed: 29232255
Biochem Med (Zagreb). 2019 Jun 15;29(2):020503
pubmed: 31223257
Semin Thromb Hemost. 2019 Feb;45(1):22-35
pubmed: 30630206
Clin Chem Lab Med. 2016 Feb;54(2):215-22
pubmed: 26351955
Arch Pathol Lab Med. 1999 Mar;123(3):199-205
pubmed: 10086507
Am J Clin Pathol. 2012 Jun;137(6):904-8
pubmed: 22586049

Auteurs

Ana Bronić (A)

Clinical Institute of Chemistry, Sestre milosrdnice University Hospital Center, Zagreb, Croatia.
Working Group for Laboratory Coagulation of the Croatian Society of Medical Biochemistry and Laboratory Medicine.

Sandra Margetić (S)

Clinical Institute of Chemistry, Sestre milosrdnice University Hospital Center, Zagreb, Croatia.
Working Group for Laboratory Coagulation of the Croatian Society of Medical Biochemistry and Laboratory Medicine.

Desiree Coen Herak (D)

Working Group for Laboratory Coagulation of the Croatian Society of Medical Biochemistry and Laboratory Medicine.
Department of Laboratory Diagnostics, University Hospital Centre Zagreb, Zagreb, Croatia.

Marija Milić (M)

Working Group for Laboratory Coagulation of the Croatian Society of Medical Biochemistry and Laboratory Medicine.
Department of Clinical Laboratory Diagnostics, University Hospital Centre Osijek, Osijek, Croatia.
Faculty of Medicine, Josip Juraj Strossmayer University of Osijek, Osijek, Croatia.

Branka Krešić (B)

Working Group for Laboratory Coagulation of the Croatian Society of Medical Biochemistry and Laboratory Medicine.
Department of Medical Laboratory Diagnostics, University Hospital Centre Split, Split, Croatia.

Vanja Radišić Biljak (V)

Working Group for Laboratory Coagulation of the Croatian Society of Medical Biochemistry and Laboratory Medicine.
Department of Medical Laboratory Diagnostics, University Hospital "Sveti Duh", Zagreb, Croatia.

Jasna Leniček Krleža (J)

Department of Laboratory Diagnostics, Children's Hospital Zagreb, Zagreb, Croatia.
Croatian Centre for Quality Assessment in Laboratory Medicine (CROQALM).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH